newsfilter
← Latest News
GlobeNewswire·

Aerpio Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update

Plan to advance AKB-9778 topical formulation into a Phase 2 trial in open angle glaucoma with top line results expected during the first quarter of 2021 Conference Call and Webcast Today, March 16,...